Related references
Note: Only part of the references are listed.Neurofilament proteins as a potential biomarker in chemotherapy-induced polyneuropathy
Petra Huehnchen et al.
JCI INSIGHT (2022)
CNS Neurotoxicity of Antiretrovirals
Tyler Lanman et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2021)
Neurofilament light chain, a biomarker for polyneuropathy in systemic amyloidosis
Jelger Louwsma et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2021)
Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy
Tomohiro Hayashi et al.
BRAIN AND BEHAVIOR (2021)
Neuroinflammation in HIV-Related Neuropathic Pain
Huan-Jun Lu et al.
FRONTIERS IN PHARMACOLOGY (2021)
Prevention of HIV-1 TAT Protein-Induced Peripheral Neuropathy and Mitochondrial Disruption by the Antimuscarinic Pirenzepine
May Madi Han et al.
FRONTIERS IN NEUROLOGY (2021)
Predictors of worsening neuropathy and neuropathic pain after 12 years in people with HIV
Ronald J. Ellis et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)
Using a surrogate marker for early testing of a treatment effect
Layla Parast et al.
BIOMETRICS (2019)
Quality of Life in Painful Peripheral Neuropathies: A Systematic Review
Ayesha Girach et al.
PAIN RESEARCH & MANAGEMENT (2019)
Chronic Distal Sensory Polyneuropathy Is a Major Contributor to Balance Disturbances in Persons Living With HIV
Duaa Z. Sakabumi et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2019)
Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies
Sara Mariotto et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2018)
Plasma neurofilament light chain concentration in the inherited peripheral neuropathies
Asa Sandelius et al.
NEUROLOGY (2018)
Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis
R. Tortelli et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Defining Neurocognitive Impairment in HIV: Deficit Scores Versus Clinical Ratings
K. Blackstone et al.
CLINICAL NEUROPSYCHOLOGIST (2012)
Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression
R. Tortelli et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Risk Factors for Falls in HIV-Infected Persons
Kristine M. Erlandson et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2012)
HIV peripheral neuropathy progression: protection with glucose-lowering drugs?
Scott R. Evans et al.
JOURNAL OF NEUROVIROLOGY (2012)
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy CHARTER Study
R. K. Heaton et al.
NEUROLOGY (2010)
CSF PROTEIN BIOMARKERS FOR PROXIMAL AXONAL DAMAGE IMPROVE PROGNOSTIC ACCURACY IN THE ACUTE PHASE OF GUILLAIN-BARRE SYNDROME
A. Petzold et al.
MUSCLE & NERVE (2009)
Differential effects of HIV infected macrophages on dorsal root ganglia neurons and axons
Katrin Hahn et al.
EXPERIMENTAL NEUROLOGY (2008)
Updated research nosology for HIV-associated neurocognitive disorders
A. Antinori et al.
NEUROLOGY (2007)
CSF neurofilament levels: A potential prognostic marker in Guillain-Barre syndrome
A. Petzold et al.
NEUROLOGY (2006)
HIV neuropathy natural history cohort study - Assessment measures and risk factors
D. M. Simpson et al.
NEUROLOGY (2006)
Clinical validation of the NeuroScreen
RJ Ellis et al.
JOURNAL OF NEUROVIROLOGY (2005)
HIV-Associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy - The Manhattan HIV brain bank
S Morgello et al.
ARCHIVES OF NEUROLOGY (2004)
HIV/AIDS-related pain as a chronic pain condition: Implications of a biopsychosocial model for comprehensive assessment and effective management
KS Marcus et al.
PAIN MEDICINE (2000)